Home > Insider Trading > Filing (0001179110-13-000738)

Filing Details

Accession Number:: 0001179110-13-000738
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-01-09 17:30:46
Reporting Period:: 2013-01-07

Filing Date:: 2013-01-09
Accepted Time:: 2013-01-09 17:30:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	Pharmaceutical Preparations (2834)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1537668	G Christopher White	100 Hayden Avenue Lexington MA 02421	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-01-07	4,000	$16.07	2,000	No	4	S	Direct
Common Stock	Acquisiton	2013-01-07	4,000	$0.00	6,000	No	4	M	Direct
Common Stock	Disposition	2013-01-08	3,000	$15.87	3,000	No	4	S	Direct
Common Stock	Disposition	2013-01-09	3,000	$15.80	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2013-01-07	4,000	$0.00	4,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,000			No	4	M	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a 10b5-1 plan adopted by the reporting person.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $15.79-$16.24. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc. (the "Issuer"), or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The shares were acquired by the reporting person as a result of the partial vesting of the restricted stock unit grant described below.
Not applicable.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $15.69-$16.08. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $15.52-$16.04. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Grant of restricted stock unit pursuant to the Issuer's Second Amended and Restated 2007 Equity Incentive Plan. This grant vests in three installments as follows: 50% on January 7, 2012, 25% on January 7, 2013 and the remaining 25% on January 7, 2014.